Johnson & Johnson will present data from two major studies supporting the performance of its recently FDA-approved Tecnis PureSee IOL at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, April 10-13 in Washington, DC. Tecnis PureSee IOL is a purely refractive Extended Depth of Focus (EDOF) IOL with improved range of vision compared to a monofocal IOL.1 “The data presented at ASCRS 2026 confirms that Tecnis PureSee IOL provides patients with high contrast sensitivity and visual acuity across distances, with low levels of visual disturbances,” said Paul Lisenby, Global Head of Research and Development, Vision, Johnson & Johnson. “This evidence underscores our commitment to advancing innovation through rigorous clinical research—extending the range of vision for our patients and reinforcing surgeon confidence.” Additional presentations will showcase positive results from the broader Tecnis family of IOLs—including evidence of their high tolerance to refractive error and range of vision. New data for Tecnis Odyssey IOL reveals high tolerance in patients with astigmatism, including high spectacle independence, and low rates of severe dysphotopsias. Additionally, new data from the Veritas Vision System showed no measurable endothelial cell count loss. Notable findings for TECNIS PureSee IOL: Results from a US prospective, randomized clinical trial involving over 200 patients across nine sites with Tecnis PureSee IOL show high-quality distance visual acuity, significantly improved intermediate vision vs monofocal control Tecnis 1-pc IOL, with some near vision gained while maintaining contrast sensitivity comparable to an aspheric monofocal IOL and low levels of visual symptoms. Three datasets will be highlighted at the meeting: Quality of Vision Clinical Outcomes for a New Extended Depth of Focus (EDOF) Intraocular Lens (IOL); Donnenfeld, MD– (Abstract) Evaluates the quality of vision of a new purely refractive extended depth of focus IOL in comparison to a standard aspheric monofocal IOL. Data shows Tecnis PureSee IOL provided: Low rates of visual disturbances Improved intermediate and near vision with higher spectacle independence compared to a monofocal IOL while maintaining contrast sensitivity and comparable distance vision acuity with pupil independent performance Depth of Focus and Visual Performance of a New Purely Refractive Extended Depth of Focus (EDOF) IOL– Daniel Chang DH, MD (Abstract) Evaluates the visual performance and patient reported outcomes of Tecnis PureSee IOL as compared to a standard aspheric monofocal IOL, showing: Strong distance-corrected intermediate vision of 20/28 (mean monocular) Some near vision gained with 1.5 lines of difference over control A broader range of clear focus, pupil independence performance and overall spectacle independence in most subjects in the Tecnis PureSee IOL group Comparison of Tolerance to Refractive Error of a New Purely Refractive Extended Depth of Focus (EDOF) IOL and Standard Monofocal IOL – Thompson, MD (Abstract) Evaluates the clinical tolerance to refractive error of a new purely refractive EDOF IOL as compared to a standard aspheric monofocal IOL, showing: 94% of patients saw distance corrected at 20/25 or better under defocus up to +/- 0.5 diopters indicating good tolerance to refractive error (mean binocular) Additional sub-group analysis showed 97% of EDOF and 94% of control patients were completely or mostly satisfied with their uncorrected overall vision Sub-group analysis also showed 92% of EDOF and 87% of control patients with refractive errors in at least one eye did not need spectacle correction for distance To further support the clinical data for Tecnis PureSee IOL, Johnson & Johnson will also share results from a real-world, post-market observation study from over 700 patients across 19 sites in Europe and Asia-Pacific showing excellent clinical outcomes, low bothersome visual symptoms, and high patient satisfaction with limited spectacle use. The lens also demonstrated a high tolerance to post-op refractive errors. Three datasets featured: Real-World Quality of Vision Outcomes in Patients Implanted with a Purely Refractive Extended Depth of Focus IOL – Schwam, MD (Abstract) Data reports multicentric real-world quality of vision results of a purely refractive EDOF PCIOL, showing: Mean binocular uncorrected distance vision of 20/19 and best corrected distance vision of 20/18 Mean binocular uncorrected intermediate and distance corrected intermediate vision of 20/26 Most patients experienced little or no bothersome glare (91%), halos (93%), and (92%) starbursts, respectively Real-World Spectacle Independence and Visual Outcomes in Patients Implanted with a Purely Refractive Extended Depth of Focus IOL – Shetty, MD (Abstract) Data reports multicentric real-world spectacle independence and visual outcomes of a purely refractive EDOF PCIOL, sh